Regeneron Pharmaceuticals (REGN)

Investing Cash Flow

-$92.70M

Quarterly · Period ending: · USD

REGN logo

REGN Investing Cash Flow

Latest reported-$92.70M
REGN Quarterly Cash from Investing (-$1.50M → -$92.70M)
High-resolution chart · PNG

REGN investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-34,577,000
6,887,000
-14,733,000
-45,460,000
8,000
2,509,000
-6,900,000
10,800,000
3,800,000
9,800,000
3,100,000
-3,800,000
8,100,000
-5,000,000
-13,400,000
-8,800,000
-14,500,000
-2,200,000
-12,400,000
-3,500,000
-14,700,000
-13,700,000
3,000,000
1,000,000
7,300,000
-3,900,000
18,400,000
3,700,000
5,400,000
4,400,000
-17,600,000
-13,100,000
5,800,000
1,300,000
3,400,000
1,200,000
1,600,000
2,000,000
-7,200,000
-1,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.